DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

AbbVie Inc. (NYSE: ABBV)

57.65 0.38 (0.66%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ABBV $57.65 0.66%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $57.63
Previous Close $57.27
Daily Range $57.31 - $58.05
52-Week Range $45.50 - $70.76
Market Cap $91.9B
P/E Ratio 52.06
Dividend (Yield) $2.04 (3.6%)
Ex-Dividend Date
Dividend Pay Date
04/13/15
05/15/15
Volume 6,829,631
Average Daily Volume 12,829,856
Current FY EPS $4.34

Sector

Industry

AbbVie Inc. (ABBV) Description

AbbVie Inc. Website: http://www.abbvie.com/

News & Commentary Rss Feed

This Market Could Grow 6250% in 10 Years

With the regulatory pathway cleared, the biosimilars market is poised to turn into a gold mine, growing up to 6,250% in 10 years. Here's where to stake your claim.

7 of the Most Audacious 'Moonshot' Projects From Google, Amazon and Facebook

US Stock Futures Edge Lower Ahead Of GDP, Consumer Sentiment Data

How Gilead And AbbVie Closed The HCV Door On Merck

4 Top-Ranked Health Care ETFs for a Healthy Portfolio - ETF News And Commentary

The Philosopher Series, Part XII: What Would Mill Invest In?

Bristol-Myers Is Playing Chess, Gilead And AbbVie Are Playing Checkers

Why My Price Target Has Increased In Biogen

11 Promising New Drugs Expected to Make Billions in Sales

Better Dividend Stock: AbbVie or Gilead Sciences, Inc.?

AbbVie and Gilead are two closely followed dividend stocks in the healthcare sector. Which one offers investors the better long-term prospects moving forward?

See More ABBV News...